Home Addition Of Amgen Drug Boosts Benefits In Relapsed Myeloma: Study
 

Keywords :   


Addition Of Amgen Drug Boosts Benefits In Relapsed Myeloma: Study

2014-12-08 09:04:12| Biotech - Topix.net

Significantly more patients with relapsed multiple myeloma responded to a three-drug regimen including Amgen Inc's Kyprolis than those who got the standard two-drug treatment, according to results from a late-stage trial. Patients with the blood cancer who received the Kyprolis regimen for 18 months also had a longer duration of response and reported better health-related quality of life, data presented on Saturday showed.

Tags: addition study benefits drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11 24.525.5cm
25.11 B
25.11SHIMANO CS-R8000 14-28t 1
25.11RADWIMPS/
25.11Delegation Delegation
25.11009 19685DVD
25.1124 C2000S
25.11stayc applemusic so bad 1
More »